Fairness of financial penalties to improve control of Clostridium difficile.

Fairness of financial penalties to improve control of Clostridium difficile.

Show other versions (1)

Bibliographic Details
Main Authors:	Walker, A, Spiegelhalter, D, Crook, D, Wyllie, D, Morris, J, Peto, T
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Fairness of financial penalties to improve control of Clostridium difficile.
by: Walker, A, et al.
Published: (2008)

Clostridium difficile mixed infection and reinfection.
by: Eyre, D, et al.
Published: (2012)

Regarding "Clostridium difficile ribotype does not predict severe infection".
by: Walker, A, et al.
Published: (2013)

Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
by: Eyre, D, et al.
Published: (2012)

Asymptomatic Clostridium difficile colonisation and onward transmission
by: Eyre, D, et al.
Published: (2013)

Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
by: Schlackow, I, et al.
Published: (2012)

Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection.
by: Stoesser, N, et al.
Published: (2011)

Effects of control interventions on Clostridium difficile infection in England: an observational study
by: Dingle, K, et al.
Published: (2017)

Risk factors for Clostridium difficile acquisition in infants: importance of study design.
by: Stoesser, N, et al.
Published: (2013)

Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
by: Walker, A, et al.
Published: (2013)

Evolutionary history of the Clostridium difficile pathogenicity locus.
by: Dingle, K, et al.
Published: (2014)

Hash-based core genome multilocus sequencing typing for Clostridium difficile
by: Eyre, DW, et al.
Published: (2019)

Patient and strain characteristics associated with Clostridium difficile transmission and adverse outcomes
by: Martin, J, et al.
Published: (2018)

Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.
by: Walker, A, et al.
Published: (2012)

Clostridium difficile in England: can we stop washing our hands? - Authors' reply.
by: Eyre, D, et al.
Published: (2017)

Multilocus sequence typing of Clostridium difficile.
by: Griffiths, D, et al.
Published: (2010)

Comparison of control of Clostridium difficile infection in six English hospitals using whole-genome sequencing
by: Eyre, D, et al.
Published: (2017)

Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
by: Dingle, K, et al.
Published: (2011)

Asymptomatic Clostridium difficile colonisation and onward transmission.
by: David W Eyre, et al.
Published: (2013-01-01)

Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative
by: Mawer, D, et al.
Published: (2017)

Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
by: Iryna Schlackow, et al.
Published: (2012-01-01)

Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission.
by: Eyre, D, et al.
Published: (2013)

Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission
by: Eyre, D, et al.
Published: (2013)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
by: Didelot, X, et al.
Published: (2012)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission.
by: Didelot, X, et al.
Published: (2012)

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile
by: Eyre, D, et al.
Published: (2013)

Clostridium difficile surveillance: harnessing new technologies to control transmission.
by: Eyre, D, et al.
Published: (2013)

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
by: Crook, D, et al.
Published: (2012)

Factors Influencing Time to Resolution of Diarrhea in Patients with Clostridium difficile Infection Treated with Fidaxomicin or Vancomycin.
by: Gerding, D, et al.
Published: (2012)

Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission.
by: Eyre, D, et al.
Published: (2013)

Two distinct patterns of Clostridium difficile diversity across Europe indicates contrasting routes of spread
by: Eyre, D, et al.
Published: (2018)

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
by: Eyre, D, et al.
Published: (2019)

Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
by: Kate E Dingle, et al.
Published: (2011-01-01)

Effect of age on treatment outcomes in Clostridium difficile infection.
by: Louie, T, et al.
Published: (2013)

The Complexity and Diversity of the Pathogenicity Locus in Clostridium difficile Clade 5.
by: Elliott, B, et al.
Published: (2014)

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease
by: Eyre, D, et al.
Published: (2013)

Clostridium difficile – an emerging plague
by: D. Spînu, et al.
Published: (2015-12-01)

RE-VISITING CLOSTRIDIUM DIFFICILE IN CHILDREN: RESERVOIR, VICTIMS, BOTH OR NONE?
by: Stoesser, N, et al.
Published: (2009)

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
by: Cornely, O, et al.
Published: (2012)

Clostridium difficile
by: Emily Macnaughton
Published: (2014-05-01)